Filip Vrbacký

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Ejection Fraction

Acute Lymphoblastic Leukemia

Top Venues

European journal of clinical investigation

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Blažek, Filip Vrbacký, Ilona Fátorová, Klára Mirská, Pavel Žák
Sysmex-derived COVID-19 prognostic score as an early prognostic marker for severity of the COVID-19 disease. International journal of laboratory hematology (2023)
Martin Simkovic, Pavel Vodárek, Monika Motyčková, Dominika Écsiová, Petra Rozsívalová, Heidi Móciková, Pavla Štěpánková, Alice Sýkorová, Kateřina Hrochová, Filip Vrbacký, David Belada, Pavel Žák, Vítězslav Bryja
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia. European journal of clinical investigation 51 (4) (2020)